Table 3.

Association between CLS-B and subsequent cancer risk

	BBD controls n = 86	BBD cases n = 86	Pa	Pb	Pc
Any CLS-B, n (%)	16 (18.6%)	21 (24.4%)	0.07	0.09	0.11
>5 CLS-B, n (%)	4 (4.7%)	9 (10.5%)	0.007	0.01	0.02
Number of CLS-B (among CLS-B-positive samples)
Median (range)	3 (1–55)	5 (1–37)	0.81	0.80	0.84
CLS-B densityd (among CLS-B-positive samples)
Median (range)	2.7 (0.7–19.7)	3.3 (0.7–27.0)	0.74	0.33	0.42
MSS, n (%)			0.54	0.73	0.93
1	25 (29.1%)	30 (34.9%)
2	37 (43.0%)	33 (38.4%)
3	24 (27.9%)	23 (26.7%)
Mean (SD)	1.99 (0.76)	1.92 (0.79)

^aP value from conditional logistic regression, adjusted for adipose area (cm²) for measures not standardized to area.

^bP value from conditional logistic regression adjusting for adipose area (cm²) as above and also histologic impression.

^cP value from conditional logistic regression adjusting for adipose area (cm²) as above and also histologic impression and BMI.

^dLesions/cm² adipose tissue